215 related articles for article (PubMed ID: 19039324)
1. Inhibitor of apoptosis proteins in hematological malignancies.
Fulda S
Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
[TBL] [Abstract][Full Text] [Related]
2. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
Fulda S
Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
4. The inhibitors of apoptosis (IAPs) as cancer targets.
Hunter AM; LaCasse EC; Korneluk RG
Apoptosis; 2007 Sep; 12(9):1543-68. PubMed ID: 17573556
[TBL] [Abstract][Full Text] [Related]
5. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
Ndubaku C; Cohen F; Varfolomeev E; Vucic D
Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
de Graaf AO; de Witte T; Jansen JH
Leukemia; 2004 Nov; 18(11):1751-9. PubMed ID: 15457181
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
[TBL] [Abstract][Full Text] [Related]
9. [IAPs: a central element in the NF-κB activating signaling pathway].
Cartier J; Marivin A; Berthelet J; Dubrez L
Med Sci (Paris); 2012 Jan; 28(1):69-75. PubMed ID: 22289833
[TBL] [Abstract][Full Text] [Related]
10. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
Kim R; Tanabe K; Uchida Y; Emi M; Inoue H; Toge T
Cancer Chemother Pharmacol; 2002 Nov; 50(5):343-52. PubMed ID: 12439591
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice.
Schimmer AD
Cancer Res; 2004 Oct; 64(20):7183-90. PubMed ID: 15492230
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-based therapies and drug targets.
Fischer U; Schulze-Osthoff K
Cell Death Differ; 2005 Aug; 12 Suppl 1():942-61. PubMed ID: 15665817
[TBL] [Abstract][Full Text] [Related]
13. The inhibitor of apoptosis protein family and its antagonists in acute leukemias.
Wrzesień-Kuś A; Smolewski P; Sobczak-Pluta A; Wierzbowska A; Robak T
Apoptosis; 2004 Nov; 9(6):705-15. PubMed ID: 15505413
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
15. RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis.
Löder S; Fakler M; Schoeneberger H; Cristofanon S; Leibacher J; Vanlangenakker N; Bertrand MJ; Vandenabeele P; Jeremias I; Debatin KM; Fulda S
Leukemia; 2012 May; 26(5):1020-9. PubMed ID: 22173242
[TBL] [Abstract][Full Text] [Related]
16. The role of protein kinase C-alpha in hematologic malignancies.
Lahn M; Sundell K; Köhler G
Acta Haematol; 2006; 115(1-2):1-8. PubMed ID: 16424642
[TBL] [Abstract][Full Text] [Related]
17. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells.
Chen J; Mehta JL; Haider N; Zhang X; Narula J; Li D
Circ Res; 2004 Feb; 94(3):370-6. PubMed ID: 14684629
[TBL] [Abstract][Full Text] [Related]
18. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
19. IAP antagonists: promising candidates for cancer therapy.
Mannhold R; Fulda S; Carosati E
Drug Discov Today; 2010 Mar; 15(5-6):210-9. PubMed ID: 20096368
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic activation of caspases in cancer: a question of selectivity.
Beauparlant P; Shore GC
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):179-87. PubMed ID: 12669453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
